Ferozsons Laboratories Limited (PSX:FEROZ)
Pakistan · Delayed Price · Currency is PKR 357.81
-7.73 (-2.11%)
At close: Nov 6, 2026
Ferozsons Laboratories Financials Overview
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 25,093 | 23,958 | 18,857 | 15,855 | 11,457 | 9,330 |
Revenue Growth | 23.81% | 27.05% | 18.93% | 38.38% | 22.80% | 5.08% |
Gross Profit Gross Profit Growth | 11,252 | 10,617 | 7,962 | 6,436 | 4,206 | 3,950 |
Operating Income Operating Income Growth | 2,446 | 2,341 | 1,935 | 1,589 | 949.17 | 1,219 |
Net Income Net Income Growth | 1,042 | 978.58 | 776.54 | 683.15 | 271.27 | 734.43 |
Earnings Per Share EPS Growth | 23.96 | 22.51 | 17.86 | 15.72 | 6.24 | 16.90 |
EPS Growth | 27.84% | 26.02% | 13.67% | 151.84% | -63.06% | -37.41% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Ferozsons Ferozsons Growth | 15,757 | 13,858 | 12,712 | 9,893 | 7,806 |
BF Biosciences BF Biosciences Growth | 9,461 | 5,837 | 3,659 | 1,810 | 1,521 |
Others Others Growth | 980.81 | 809.37 | 604.3 | 459.38 | 368.33 |
Inter-Segment Elimination /Adjustment Inter-Segment Elimination /Adjustment Growth | -2,241 | -1,648 | -1,120 | -705.06 | -365.53 |
Total Total Growth | 23,958 | 18,857 | 15,855 | 11,457 | 9,330 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 1,094 | 1,053 | 2,354 | 1,048 | 1,114 | 2,452 |
Total Debt Total Debt Growth | 3,928 | 4,252 | 4,292 | 4,920 | 3,482 | 2,171 |
Net Cash (Debt) Net Cash Growth | -2,835 | -3,199 | -1,938 | -3,872 | -2,368 | 280.9 |
Net Cash Growth | - | - | - | - | - | -82.79% |
Net Cash Per Share Net Cash Per Share Growth | -65.21 | -73.59 | -44.59 | -89.08 | -54.47 | 6.46 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 268.93 | 428.09 | 1,436 | -535.33 | -513.85 | 296.92 |
Capital Expenditures CapEx Growth | -1,387 | -1,178 | -663.57 | -544.04 | -2,347 | -1,754 |
Free Cash Flow Free Cash Flow Growth | -1,118 | -749.6 | 771.95 | -1,079 | -2,861 | -1,457 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 44.84% | 44.32% | 42.22% | 40.60% | 36.71% | 42.34% |
Operating Margin | 9.75% | 9.77% | 10.26% | 10.02% | 8.28% | 13.07% |
Pretax Margin | 8.59% | 8.59% | 8.25% | 7.19% | 3.62% | 13.26% |
Profit Margin | 4.15% | 4.08% | 4.12% | 4.31% | 2.37% | 7.87% |
FCF Margin | -4.46% | -3.13% | 4.09% | -6.81% | -24.97% | -15.62% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 5.500 | 5.500 | 4.000 | 3.000 | - | 4.167 |
Dividend Per Share Growth | 37.50% | 37.50% | 33.33% | - | - | -50.00% |
Dividend Yield | 1.54% | 1.36% | 1.03% | 1.20% | - | 1.86% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.93 | 17.91 | 21.81 | 15.87 | 21.93 | 13.26 |
Forward PE | - | 9.70 | 9.70 | 9.48 | 9.59 | 9.59 |
P/FCF Ratio | - | - | 21.94 | - | - | - |
PS Ratio | 0.63 | 0.73 | 0.90 | 0.68 | 0.52 | 1.04 |